Characterizing the Transcriptional Features That Underlie Established Injury and Disease Progression in Diabetic Kidney Disease
Kidney360 · 2026-10 · 7 (10) · 2186-2201
DOI: 10.34067/kid.0000001319 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, online erschienen am 16.09.2026. Verfasst von Paraish S Misra und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Keenan Research Centre for Biomedical Science, St. Michael's Hospital (Unity Health Toronto), Li Ka Shing Knowledge Institute…. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Kidney, Transcriptome. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAN-SOLVE CKD Network, St. Michael's Hospital Foundation, Canada Research Chairs, Morris A. Hunter Charitable Trust, Banting and Best Diabetes Centre, Universi…, CAN-SOLVE CKD Network, St. Michael's Hospital Foundation.
Abstract (Originalsprache)
Key Points Diabetic kidney disease is characterized by a specific transcriptional pattern associated with inflammation and fibrosis, as well as downregulation of metabolic activity. Genes associated with rapid kidney function loss are mostly unique and not associated with other clinical and histopathologic features. Rapid kidney function loss in diabetic kidney disease is associated with lower expression of transcripts related to intercalated cell function and identity.
Background
Diabetes is the leading cause of kidney failure in the developed world. Despite its importance, the molecular events driving the pathogenesis of diabetic kidney disease (DKD) remain incompletely understood. We thus sought to use transcriptional profiling of kidney biopsy tissue to uncover relationships between transcriptional features and clinical parameters related to established kidney injury and disease progression.
Methods
Using bulk RNA sequencing, we comprehensively explored the human diabetic kidney transcriptome in the largest cohort of patients with DKD to be transcriptionally profiled to date. These data were combined with clinical indices of established injury (eGFR, urinary albumin‑creatinine ratio, interstitial fibrosis, and glomerulosclerosis) and disease progression (rate of eGFR decline and progression to ESKD) and integrated with previously published mouse and human datasets to better delineate the transcriptional features that characterize this disease.
Results
We profiled 50 diabetic kidney and 13 healthy control biopsies, identifying a global transcriptional signature of human DKD, which included nearly universal upregulation of NNMT and CD209 and downregulation of DUSP1. We next correlated the diabetic kidney transcriptome with parameters associated with established DKD injury, which we used to derive a molecular index of disease stage in DKD. Finally, using both the rate of eGFR decline and documented progression to kidney failure, we observed a novel association between slower progression of kidney disease and expression of genes related to intercalated cell functional identity, such as FOXI1 and subunits of the V-ATPase proton pump.
Conclusions
In addition to shedding light on the molecular events underpinning its pathogenesis, our data will serve as a valuable resource to help accelerate the discovery of improved diagnostics and therapeutics for DKD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Keenan Research Centre for Biomedical Science, St. Michael's Hospital (Unity Health Toronto), Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Ontario, Canada.
- Department of Molecular Genetics, Center for Systems Biology, Mount Sinai Hospital, Lunenfeld-Tanenbaum Research Institute, University of Toronto, Toronto, Ontario, Canada.
- Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital (Unity Health Toronto), University of Toronto, Toronto, Ontario, Canada.
- Division of Nephrology, Department of Medicine, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
ORCID-Profile: Paraish S Misra, Shukai Huang, Lauren Caldwell, Xiaolin He, Tianzhou Zhang, Kevin D Burns, Jeffrey L Wrana, Darren A Yuen
Förderung
- CAN-SOLVE CKD Network, St. Michael's Hospital Foundation, Canada Research Chairs, Morris A. Hunter Charitable Trust, Banting and Best Diabetes Centre, Universi…
- CAN-SOLVE CKD Network
- St. Michael's Hospital Foundation
- Canada Research Chairs
- Morris A. Hunter Charitable Trust
- Banting and Best Diabetes Centre, University of Toronto
Zitieren
APA
Misra, P. S., Huang, S., Caldwell, L., He, X., Zhang, T., Krizova, A., Burns, K. D., Gilbert, R. E., Wrana, J. L., & Yuen, D. A. (2026). Characterizing the Transcriptional Features That Underlie Established Injury and Disease Progression in Diabetic Kidney Disease. Kidney360, 7(10), 2186-2201. https://doi.org/10.34067/kid.0000001319
Vancouver
Misra PS, Huang S, Caldwell L, He X, Zhang T, Krizova A, et al. Characterizing the Transcriptional Features That Underlie Established Injury and Disease Progression in Diabetic Kidney Disease. Kidney360. 2026;7(10):2186-2201. doi:10.34067/kid.0000001319
BibTeX
@article{Misra2026,
author = {Misra, Paraish S and Huang, Shukai and Caldwell, Lauren and He, Xiaolin and Zhang, Tianzhou and Krizova, Adriana and Burns, Kevin D and Gilbert, Richard E and Wrana, Jeffrey L and Yuen, Darren A},
title = {Characterizing the Transcriptional Features That Underlie Established Injury and Disease Progression in Diabetic Kidney Disease},
journal = {Kidney360},
year = {2026},
volume = {7},
number = {10},
pages = {2186--2201},
doi = {10.34067/kid.0000001319}
}
EUVIMED